StreetInsider.com News Articles

Form SCHEDULE 13G/A Kimball Electronics, Filed by: MANAGED ACCOUNT ADVISORS LLC

Tue, 10 Feb 2026 13:49:00 -0500

si-local-file:///var/storage/secattach/20260210/25974467.html

Form SCHEDULE 13G/A Kimball Electronics, Filed by: MANAGED ACCOUNT ADVISORS LLC

Tue, 10 Feb 2026 13:49:00 -0500

si-local-file:///var/storage/secattach/20260210/25974467.html

Form 10-Q Kimball Electronics, For: Dec 31

Thu, 05 Feb 2026 16:55:00 -0500

si-local-file:///var/storage/secattach/20260205/25955937.html

Form 10-Q Kimball Electronics, For: Dec 31

Thu, 05 Feb 2026 16:55:00 -0500

si-local-file:///var/storage/secattach/20260205/25955937.html

Form 8-K Kimball Electronics, For: Feb 04

Wed, 04 Feb 2026 16:50:00 -0500

si-local-file:///var/storage/secattach/20260204/25947978.html

Form 8-K Kimball Electronics, For: Feb 04

Wed, 04 Feb 2026 16:50:00 -0500

si-local-file:///var/storage/secattach/20260204/25947978.html

Kimball Electronics (KE) Tops Q2 EPS by 2c, provides guidance

Wed, 04 Feb 2026 16:11:33 -0500

Kimball Electronics (NASDAQ: KE) reported Q2 EPS of $0.28, $0.02 better than the analyst estimate of $0.26. Revenue for the quarter came in at $341.3 million versus the consensus estimate of $342.98 million.

GUIDANCE:

Kimball Electronics sees Q3 2026 revenue of $1.4-1.46 billion, versus the consensus of $1.404 billion.

For earnings history and earnings-related data on Kimball Electronics (KE) click here.

Kimball Electronics (KE) Tops Q2 EPS by 2c, provides guidance

Wed, 04 Feb 2026 16:11:33 -0500

GUIDANCE:

Kimball Electronics sees Q3 2026 revenue of $1.4-1.46 billion, versus the consensus of $1.404 billion.

For earnings history and earnings-related data on Kimball Electronics (KE) click here.

Kimball Electronics Reports Q2 Results; With Strong Sales Growth in the Medical Vertical; Company Raises Its Guidance for Fiscal 2026

Wed, 04 Feb 2026 16:08:00 -0500

Second Quarter 2026 Highlights

Revenue of $341.3 million, a 5% decrease compared to Q2 of fiscal 2025
Sales in the medical vertical increased 15% year-over-year
Operating income of $10.8 million, or 3.2% of net sales
Adjusted operating income of 4.5%, up 80 bps year-over-year
Cash from operations of $6.9 million, the eighth consecutive quarter of positive operating cash generation
Debt of $154.2 million and borrowing capacity of $285.1 million
Cash Conversion Days of 91, a 16-day improvement compared to the same period last year
Invested $4.3 million to repurchase 149,000 shares of common stock
Company increases guidance for fiscal 2026 sales and adjusted operating income

Kimball Electronics Reports Q2 Results; With Strong Sales Growth in the Medical Vertical; Company Raises Its Guidance for Fiscal 2026

Wed, 04 Feb 2026 16:08:00 -0500

Second Quarter 2026 Highlights

Revenue of $341.3 million, a 5% decrease compared to Q2 of fiscal 2025
Sales in the medical vertical increased 15% year-over-year
Operating income of $10.8 million, or 3.2% of net sales
Adjusted operating income of 4.5%, up 80 bps year-over-year
Cash from operations of $6.9 million, the eighth consecutive quarter of positive operating cash generation
Debt of $154.2 million and borrowing capacity of $285.1 million
Cash Conversion Days of 91, a 16-day improvement compared to the same period last year
Invested $4.3 million to repurchase 149,000 shares of common stock
Company increases guidance for fiscal 2026 sales and adjusted operating income

Kimball Electronics Reports Q2 Results; With Strong Sales Growth in the Medical Vertical; Company Raises Its Guidance for Fiscal 2026

Wed, 04 Feb 2026 16:08:00 -0500

Second Quarter 2026 Highlights

Revenue of $341.3 million, a 5% decrease compared to Q2 of fiscal 2025
Sales in the medical vertical increased 15% year-over-year
Operating income of $10.8 million, or 3.2% of net sales
Adjusted operating income of 4.5%, up 80 bps year-over-year
Cash from operations of $6.9 million, the eighth consecutive quarter of positive operating cash generation
Debt of $154.2 million and borrowing capacity of $285.1 million
Cash Conversion Days of 91, a 16-day improvement compared to the same period last year
Invested $4.3 million to repurchase 149,000 shares of common stock
Company increases guidance for fiscal 2026 sales and adjusted operating income

Kimball Electronics Reports Q2 Results; With Strong Sales Growth in the Medical Vertical; Company Raises Its Guidance for Fiscal 2026

Wed, 04 Feb 2026 16:08:00 -0500

Second Quarter 2026 Highlights

Revenue of $341.3 million, a 5% decrease compared to Q2 of fiscal 2025
Sales in the medical vertical increased 15% year-over-year
Operating income of $10.8 million, or 3.2% of net sales
Adjusted operating income of 4.5%, up 80 bps year-over-year
Cash from operations of $6.9 million, the eighth consecutive quarter of positive operating cash generation
Debt of $154.2 million and borrowing capacity of $285.1 million
Cash Conversion Days of 91, a 16-day improvement compared to the same period last year
Invested $4.3 million to repurchase 149,000 shares of common stock
Company increases guidance for fiscal 2026 sales and adjusted operating income

Kimball Electronics, Inc. Announces Date For Reporting Second Quarter Fiscal Year 2026 Financial Results

Wed, 21 Jan 2026 15:56:00 -0500

JASPER, Ind.--(BUSINESS WIRE)-- Kimball Electronics, Inc. (Nasdaq: KE) today announced that it will report second quarter fiscal year 2026 financial results on Wednesday, February 4, 2026, after the closing of the market. The company will host a conference call and live webcast to review the results on Thursday, February 5, 2026, at 10:00 a.m. Eastern Time.

The telephone number to access the conference call is 877-407-8293 / +1 201-689-8349.
A live webcast of the conference call can be accessed at investors.kimballelectronics.com. For those unable to participate in the live webcast, a replay will be

Kimball Electronics, Inc. Announces Date For Reporting Second Quarter Fiscal Year 2026 Financial Results

Wed, 21 Jan 2026 15:56:00 -0500

The telephone number to access the conference call is 877-407-8293 / +1 201-689-8349.
A live webcast of the conference call can be accessed at investors.kimballelectronics.com. For those unable to participate in the live webcast, a replay will be

Kimball Electronics, Inc. Announces Date For Reporting Second Quarter Fiscal Year 2026 Financial Results

Wed, 21 Jan 2026 15:56:00 -0500

The telephone number to access the conference call is 877-407-8293 / +1 201-689-8349.
A live webcast of the conference call can be accessed at investors.kimballelectronics.com. For those unable to participate in the live webcast, a replay will be

Kimball Electronics, Inc. Announces Date For Reporting Second Quarter Fiscal Year 2026 Financial Results

Wed, 21 Jan 2026 15:56:00 -0500

The telephone number to access the conference call is 877-407-8293 / +1 201-689-8349.
A live webcast of the conference call can be accessed at investors.kimballelectronics.com. For those unable to participate in the live webcast, a replay will be

Form 8-K Kimball Electronics, For: Jan 08

Thu, 08 Jan 2026 16:16:00 -0500

si-local-file:///var/storage/secattach/20260108/25826911.html

Form 8-K Kimball Electronics, For: Jan 08

Thu, 08 Jan 2026 16:16:00 -0500

si-local-file:///var/storage/secattach/20260108/25826911.html

Kimball Electronics Announces Date for Ribbon-Cutting Ceremony at New Medical Manufacturing Facility in Indianapolis

Thu, 08 Jan 2026 16:05:00 -0500

Company Intends to Rebrand as Kimball Solutions as It Celebrates 65 Years of Excellence

A legacy of innovation continues with a new name and expanded capabilities to serve customers globally

JASPER, Ind.--(BUSINESS WIRE)-- Kimball Electronics, Inc. (Nasdaq: KE) today announced the date for the ribbon-cutting ceremony at its new medical manufacturing facility in Indianapolis. On Friday, February 6, 2026, Kimball executives, local officials, and community leaders will gather at the new facility located at 1220 Post Road, Indianapolis, IN, to celebrate the opening of Kimball’s advanced manufacturing and innovation hub serving the medical and life sciences industries. The event

Kimball Electronics Announces Date for Ribbon-Cutting Ceremony at New Medical Manufacturing Facility in Indianapolis

Thu, 08 Jan 2026 16:05:00 -0500

Company Intends to Rebrand as Kimball Solutions as It Celebrates 65 Years of Excellence

A legacy of innovation continues with a new name and expanded capabilities to serve customers globally

Kimball Electronics Announces Date for Ribbon-Cutting Ceremony at New Medical Manufacturing Facility in Indianapolis

Thu, 08 Jan 2026 16:05:00 -0500

Company Intends to Rebrand as Kimball Solutions as It Celebrates 65 Years of Excellence

A legacy of innovation continues with a new name and expanded capabilities to serve customers globally

Kimball Electronics Announces Date for Ribbon-Cutting Ceremony at New Medical Manufacturing Facility in Indianapolis

Thu, 08 Jan 2026 16:05:00 -0500

Company Intends to Rebrand as Kimball Solutions as It Celebrates 65 Years of Excellence

A legacy of innovation continues with a new name and expanded capabilities to serve customers globally

Form 4 Kimball Electronics, For: Jan 04 Filed by: Phillips Richard D

Tue, 06 Jan 2026 14:30:00 -0500

si-local-file:///var/storage/secattach/20260106/25812485.html

Form 4 Kimball Electronics, For: Jan 04 Filed by: Phillips Richard D

Tue, 06 Jan 2026 14:30:00 -0500

si-local-file:///var/storage/secattach/20260106/25812485.html

Kimball Electronics promotes treasurer to strategic development role

Tue, 02 Dec 2025 08:30:53 -0500

Kimball Electronics, Inc. (NASDAQ: KE) announced Andrew D. Regrut has been promoted to an expanded role that includes leading strategic development efforts for the company. Regrut previously served as Treasurer and Investor Relations Officer.

In his new position, Regrut will report to Chief Financial Officer Jana T. Croom as a Section 16 Officer. Croom stated that Regrut "has been instrumental in our recent efforts to optimize debt levels through improved working capital management and global cash movement."

The Jasper, Indiana-based electronics manufacturer also announced it will participate in the Piper Sandler 37th Annual Healthcare Conference scheduled for December 2-4, 2025, at The